Product Catalogue

SGD Pharma announces that its 20ml EasyLyo molded glass Type I vials are now available Ready-to-Use (RTU) in SG EZ-fill® Nest & Tub – an industry-recognized state-of-the-art secondary packaging format.

SGD Pharma extends Sterinity molded glass vial platform, with the introduction of amber glass 50ml.

Explore the world of SGD Pharma packaging. Find the best solution for your product.

Strengthened value propositions represent the latest step in SGD Pharma’s commitment to continuous improvement 

The leading packaging solution that combines exceptional quality vials designed to suit the most demanding, high-value therapeutic products, alongside tailored expert guidance, and priority technical and regulatory support services. AXpert Type I molded glass vials are subject to our usual online automated inspection as well as additional offline quality control, offering the highest cosmetic quality and minimizing post-filling loss of valuable product.

Through its sustainable, environmental and CSR efforts, SGD Pharma has received a platinum award that positions it in the top 1% of rated companies

Reliable, high-quality glass vials for essential or primary care drugs requiring optimized inert packaging options. AXess supports manufacturers’ ability to remain flexible in a dynamic and challenging pharmaceutical marketplace where optimizing Total Cost of Ownership (TCO) is vital.

Discover all key features and benefits of plastic coating options offered by SGD Pharma

Superior quality vials suitable for the widest range of parenteral drug applications, with a variety of options for customization, from vial design to palletization. AXecure is the de-facto standard solution for parenteral packaging that helps to maximize the value of your therapeutic products without compromising your bottom line.

SGD Pharma has expanded its ready-to-use (RTU) molded glass vial range to introduce a market-first 50ml volume option in tray developed at introduce a market-first 50ml volume option in tray developed at industrial scale by a molded glass manufacturer.

Sterinity
SGD Pharma partnering with SG EZ-fill® to offer washed, sterilized and depyrogenated high-quality Type I molded glass vials.A secondary packaging designed in collaboration with thehighest quality machine suppliers and optimized to:· Grant the vial sterility until the aseptic area
· Avoid contamination
· Protect the physical integrity of the vials
· Match the filling technology standards. 

SGD Pharma today announces the launch of its new full packaging solution dedicated to the cannabidiol (CBD) oil market. Combining the company’s extensive pharmaceutical packaging expertise with the need for compliant, safe packaging for CBD oils, SGD Pharma has developed Ensiemo – a glass dropper and bottle offering that meets international regulatory standards.

EasyLyo
Symply Stronger Vials

A whole range of injectable molded glass vials with better chemical durability, greater physical strength and improved cosmetic.

The pharmaceutical packaging specialist is preparing to relaunch an investment plan of 37 million euros in its two French factories

Clareo

Type II Premium Injection Vials
In a process of continuous improvement, the R&D teams of SGD Pharma focus on pharmaceutical glass performances and patient safety.

As a result, Clareo, the highest quality Type II premium injection vials are available on the market.

As a key supplier to the global pharmaceutical industry, SGD Pharma is well versed in the process of contingency planning. This experience has greatly assisted the specialist glass packaging manufacturer in implementing its response to the Covid-19 pandemic, with melting at all five production sites continuing to run at full capacity throughout the crisis.

Ensiemo is a glass dropper and bottle offering that meets international regulatory standards. Ensiemo is available in 10ml, 15ml and 30ml bottles, in clear or amber glass, with two teat types on offer for CRC, and a range of pipette tip shape options.

SGD Pharma, one of That's Nice's Road to 2021 sponsors, discusses how the company is innovating to face the challenges of the COVID-19 pandemic and beyond to face the future of healthcare.

Type I Molded Glass


Type I molded glass vials have high degree of hydrolytic & thermal shock resistance due to their superior chemical composition.

Our Type I molded glass vials are available in flint and amber glass.

Drugmakers are warning of a potential shortage of vials to bottle future COVID-19 vaccines, but their rush to secure supplies risks making matters worse, some major medical equipment manufacturers warn.

SGD Pharma India tubular vials and ampoules are made of neutral Borosilicate glass of 5.0 expansion coefficient family. The tube used by SGD Pharma India is supplied by globally renowned tubing manufacturers like Schott, NEG, Corning and others as per the specifications of our clients.

Our commitment to the pharmaceutical market remains in full swing. We increased our range of Syrup bottles designed according to the Brazilian standards

Société de Services Verriers (SSV) has built its reputation as a preferred partner for the pharmaceutical and cosmetics industries based on its commitment to quality requirements.


Located in the heart of the Glass Valley, a French region globally known for glass containers production, SSV inspects over 150 million glass containers annually. The experience SSV has gained in over 40 years and a focus on tailoring the work to meet client’s specific objectives; makes SSV the indisputable leader in France’s glass inspection and services sector.

Siliconization
A special treatment adding value to your product.

SGD Pharma’s plastified glass packaging for pharma applications combines the most desirable qualities of both materials to deliver a robust, premium, fully customizable packaging solution. It offers a unique opportunity to deliver your productin perfect condition, in a distinctive branded wrapping. Whether your goal is to safeguard product quality, extend shelf life and ensure rugged protection, or to boost visual appeal, SGD Pharma's high value plastic coated glass will suit your application. Wrapping glass in plastic improves its mechanical resistance further, lowering drastically the risk of shattering, eliminating the risk of injury for the patient, while at the same time opening up new design opportunities for your brand.

Our corporate Strategy is aligned with the United Nations Sustainable Development Goals. The Sustainable Development Goals are the blueprint to achieve a better and more sustainable future for all.  SGD Pharma men and women are daily involved to contribute to satisfy our customers as well as to support sustainable development with focus on three main axes: Our People - Our Business Values - Our Environmental Impact.

Based on our core values, and as a leader in molded glass pharmaceutical packaging, SGD Pharma considers prioritizing CSR to be both a responsibility as well as an opportunity to enhance our company’s performance. We are proud to present this second CSR report as a contribution to a better planet, fully in line with our long-term vision.

Our Convictions At SGD Pharma, we have the strong conviction that glass packaging can significantly contribute to a safer and better environment.

Glass packaging offers exceptional benefits: Sustainable, Chemically Neutral, Potentially Infinitely Recyclable.

Our Commitments Based on our core values, and as a leader in molded glass pharmaceutical packaging, SGD Pharma considers prioritizing CSR to be both a responsibility as well as an opportunity to enhance our company’s performance.

Our CSR strategy revolves around three major axes: people, impact and values. In every aspect of our business, we are committed to empowering our employees, promoting the best health and safety practices, protecting the environment and maintaining exemplary ethical standards.

Welcome to SGD Pharma, a leader in glass pharmaceutical packaging for healthcare.

Our unique know-how and capabilities deliver innovative and premium quality packaging solutions that meet and exceed international pharmacopoeia requirements. From design to manufacturing, our teams will support you to develop and realize your project.

As a result of the higher volume of injectable glass vials diverted to the supply of COVID-19 vaccines, some pharma companies are facing shortages of containers, particularly amber tubular vials, for pharmaceuticals and biological parenteral products. We’re on hand to meet the urgent needs of drug manufacturers with the immediate availability of our molded glass vials. Get in touch today to ensure continuity of drug supply to market. 

https://www.sgd-pharma.com/type-i-molded-glass-vials

Our world-renowned expertise in Type I molded glass manufacture for pharmaceutical primary packaging places our solutions, and our customers, at the forefront of innovation. We’re committed to developing best-in-class, high quality vials and bottles for the most challenging parenteral drugs. 

SGD Pharma is using its world-class expertise to help match you with the best fitting packaging and services solution based on your unique business and product requirements.

The leading quality packaging solution ideally suited to the most demanding parenteral drug applications.

Discore more: https://www.sgd-pharma.com/parenteral-type-i-offer

Reliable glass packaging solutions at the cutting-edge of flexibility and security.

More: https://www.sgd-pharma.com/parenteral-type-i-offer

Consistently meets quality expectations for parenteral packaging.
More: https://www.sgd-pharma.com/parenteral-type-i-offer

SGD Pharma speeds up time to market with industry first Ready-to-Use SG EZ-fill® Nest & Tub packaging solution for molded glass vials for parenteral drugs . 

SGD Pharma announces that its 20ml EasyLyo molded glass Type I vials are now available Ready-to-Use (RTU) in SG EZ-fill® Nest & Tub – an industry-recognized state-of-the-art secondary packaging format.


Increased demand for parenteral drugs generated by the Covid-19 pandemic has resulted in additional pressures being placed on biopharmaceutical companies to accelerate their time-to-market. This new RTU primary and secondary packaging combination from SGD Pharma offers biopharmaceutical producers the flexibility they need to deliver innovative medicines to patients significantly faster. 


More: https://www.sgd-pharma.com/sgd-pharma-speeds-time-market-with-industry-first-ready-use-sg-ez-fillr-nest-tub-packaging-solution

According to the U.S. FDA, glass vials manufactured under intense heat are associated with a higher incidence of glass lamellae formation (delamination). Molded glass has a naturally lower delamination risk, which is further strengthened by SGD Pharma’s EasyLyo vial design with its superior hydrolytic resistance for the protection of valuable drug products. 

Watch the video to find out more.


www.sgd-pharma.com

Find the best solution for your product. Solutions for every sector!
https://www.sgd-pharma.com/therapeutic-classes/anaesthetics

Find the best solution for your product. Solutions for every sector!
https://www.sgd-pharma.com/therapeutic-classes/anaesthetics

Pharma industry identification & cross-reference guide to visual non-conformities found in molded glass bottles & vials.

Resulting from a development project between SGD Pharma Quality and Marketing departments, this digital tool makes it possible to identify non-compliances that may be discovered during an incoming inspection or during on-line inspection at client's side. The SGD Pharma App is a testament to our commitment to continuous improvement. It also demonstrates transparency in working with customers toward the mutual objective of safeguarding patient health.

For more details: https://www.sgd-pharma.com/company-news/sgd-pharma-app

In a process of continuous improvement, the R&D teams of SGD Pharma focus on pharmaceutical glass performances and patient safety. As a result, Clareo, the best quality Type II premium injection vial is available on the market.

SGD Pharma offers a high-quality range of clear and amber bottles and dropper assemblies ideally suited for oil product formulations. They feature pharmaceutical grade glass with precise and accurate dropper dosage resulting in virtually no product waste. This convenient and functional combination can also include the following features: - Child-resistant packaging systems certified ISO 8317 & US CFR 16 1700.20 
- Senior friendly
 - Product integrity features with Tamper Evidence (TE)  


For more details, please visit: https://www.sgd-pharma.com/ensiemo or download the brochure here: https://bit.ly/3i7QoPN

The cannabidiol (CBD) market continues to grow rapidly, with regulations varying across different geographies and undergoing continuous updates. CBD manufacturers must not only navigate the CBD regulatory landscape, but that of cannabis itself, as well as pharmaceutical and food packaging and labelling, making it one of the most complex markets to operate in. Our white paper reflects these ongoing developments. 

Download our white paper: https://www.sgd-pharma.com/whitepapers/navigating-the-cannabidiol-regulatory-landscape

Despite a reduction in cases in recent years, unintentional child poisoning remains a considerable risk in the home, with over-the-counter and prescription medicines presenting the greatest risk. Patients and stakeholders are calling upon the pharmaceutical industry to recognize the importance of child-resistant closures (CRCs) in medical packaging that is effective at preventing young children opening medication, while remaining accessible to senior patients. By partnering with packaging manufacturers that can offer certified child-resistant packaging solutions, pharmaceutical companies can guarantee their products meet relevant regulatory requirements.
Download the white paper: https://www.sgd-pharma.com/whitepapers/protecting-children-with-child-resistant-packaging 

EasyLyo
Simply stronger molded glass vials
Still having issues processing glass ? Well, this is awkward. Watch the video!

Internal siliconization of the vials, an adding value coating.


Internal siliconization allows to maintain a complete transparency of the bottles and allows the patients to use their drug up to the last drop of aqueous solutions respecting the delivered dose of active ingredients.

Highly complex biologics and other speciality drugs are representing an increasing proportion of the pharmaceutical market, and their pivotal role in this market has been challenging glass primary packaging producers year after year. Together with this, trends such as more personalized treatments in place of blockbuster drugs, increasing regulatory quality and compliance requirements, and a move towards more self-medication, are changing the way drugs are administered and therefore manufactured. Pharmaceutical companies are requested to be flexible, to reduce time-to-market, increasing quality and reducing costs. To meet the needs of the market and address these challenges, primary packaging design is moving towards ready-to-use (RTU) components as a preferred solution.
https://www.sgd-pharma.com/whitepapers/increasing-flexibility-pharmaceutical-packaging-aseptic-filling

An evaluation of current and future child-resistant packaging trends in the pharmaceutical industry.
Despite a reduction in cases in recent years, unintentional child poisoning remains a considerable risk in the home, with over-the-counter and prescription medicines presenting the greatest risk. Patients and stakeholders are calling upon the pharmaceutical industry to recognize the importance of child-resistant closures (CRCs) in medical packaging that is effective at preventing young children opening medication, while remaining accessible to senior patients. By partnering with packaging manufacturers that can offer certified child-resistant packaging solutions, pharmaceutical companies can guarantee their products meet relevant regulatory requirements, avoid brand damage and fines through non-compliance, and keep children safe from poisoning.

https://www.sgd-pharma.com/whitepapers/protecting-children-with-child-resistant-packaging

Discover the latest global regulatory updates in the fast-moving CBD industry.
The cannabidiol (CBD) market continues to grow rapidly, with regulations varying across different geographies and undergoing continuous updates. CBD manufacturers must not only navigate the CBD regulatory landscape, but that of cannabis itself, as well as pharmaceutical and food packaging and labelling, making it one of the most complex markets to operate in.

We have updated our white paper to reflect these ongoing developments, now including insights from Croatia, Hungary, Poland, Czech Republic, Bulgaria, Russia, Romania, Macedonia, and Israel.
https://www.sgd-pharma.com/whitepapers/navigating-the-cannabidiol-regulatory-landscape

SGD Pharma has partnered with Stevanato Group EZ-fill to offer washed, depyrogenated and sterilized "Ready-to-Use" Type I molded glass vials. Available from 20 to 100 ml, in clear or amber glass, Tray or Nest & Tub pack.

Discover the latest global regulatory updates in the fast-moving CBD industryThe cannabidiol (CBD) market continues to grow rapidly, with regulations varying across different geographies and undergoing continuous updates. CBD manufacturers must not only navigate the CBD regulatory landscape, but that of cannabis itself, as well as pharmaceutical and food packaging and labelling, making it one of the most complex markets to operate in.

We have updated our white paper to reflect these ongoing developments, now including insights from Croatia, Hungary, Poland, Czech Republic, Bulgaria, Russia, Romania, Macedonia, and Israel.

Download the new white paper for a closer look at:

What CBD is and how it is usedHow CBD is regulated in key countries in Europe, North America, the Middle East, and Latin AmericaImportant updates including the recent European Court of Justice ruling on the legality of CBD in FranceThe vital role of compliant pharmaceutical-grade packaging in relieving regulatory concerns.
https://www.sgd-pharma.com/whitepapers/navigating-the-cannabidiol-regulatory-landscape

Learn how to achieve true flexibility and compliance in aseptic fill/ finish lines.Ready-to-use (RTU) glass containers are enabling Pharma Companies to keep pace with the growing complex biologics and other specialty drugs market. By increasing flexibility, reducing time-to-market and total cost of ownership (TCO), and preserving safety and quality standards of the system, RTU molded glass vials now offer a new choice in aseptic manufacturing processes and technologies. Molded glass brings improved chemical durability and greater mechanical strength, combined with the well-proven secondary packaging platform designed for RTU vials, such as Tray and Nest&Tub.

Take a closer look at:

A review of RTU packaging trendsThe advantages of RTU molded glass vialsThe benefits of an integrated primary and secondary RTU packaging solution.
https://www.sgd-pharma.com/whitepapers/increasing-flexibility-pharmaceutical-packaging-aseptic-filling

Understand the evolving child-resistant packaging market and current regulationsDespite a reduction in cases in recent years, unintentional child poisoning remains a considerable risk in the home, with over-the-counter and prescription medicines presenting the greatest risk. Patients and stakeholders are calling upon the pharmaceutical industry to recognize the importance of child-resistant closures (CRCs) in medical packaging that is effective at preventing young children opening medication, while remaining accessible to senior patients. By partnering with packaging manufacturers that can offer certified child-resistant packaging solutions, pharmaceutical companies can guarantee their products meet relevant regulatory requirements, avoid brand damage and fines through non-compliance, and keep children safe from poisoning.

Download the white paper to learn:

How current trends are driving developments in child-resistant packagingThe role of pharmaceutical companies in driving CRC awareness and innovation in the industryThe results of recent research into both novel approaches to packaging design, and proposed changes to current child-resistant packaging test criteriaThe opinions of industry experts on the future of the child-resistant packaging landscapeHow strong collaborations between drug manufacturers and packaging suppliers accelerate advances in child-resistant packaging.

https://www.sgd-pharma.com/whitepapers/protecting-children-with-child-resistant-packaging

Our corporate Strategy is aligned with the United Nations Sustainable Development Goals. The Sustainable Development Goals are the blueprint to achieve a better and more sustainable future for all.  SGD Pharma men and women are daily involved to contribute to satisfy our customers as well as to support sustainable development with focus on three main axes: Our People - Our Business Values - Our Environmental Impact.

Based on our core values, and as a leader in molded glass pharmaceutical packaging, SGD Pharma considers prioritizing CSR to be both a responsibility as well as an opportunity to enhance our company’s performance. We are proud to present this second CSR report as a contribution to a better planet, fully in line with our long-term vision.